ArticleInternational journal of psychological research
Adequate Levels of Vitamin D Are Protective of Executive Functions in Patients with Chronic Mental Health.
Article in International journal of psychological research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Vitamin D is a neurosteroid that modulates multiple brain functions and may be involved in the clinical presentation of psychotic disorders. Vitamin D deficiency has been associated with schizophrenia and cognitive decline, particularly in executive functions. Objective: To evaluate the relationship between vitamin D levels and performance in executive functions, processing speed, accuracy, and concentration in patients with schizophrenia and other organic mental disorders. Method: Retrospective, cross-sectional study with convenience sampling. The sample consisted of 113 adults (66 with schizophrenia and 47 with other organic mental conditions) admitted to the Institute of Neurosciences of Guayaquil, aged between 22 and 85 years. Results: The findings indicate a significant correlation between vitamin D levels and executive function performance. Higher levels of vitamin D were associated with less decline in executive functions in patients with schizophrenia and organ damage. Processing speed was higher in patients with optimal vitamin D levels compared to those with deficiency. In patients with organ damage, low vitamin D levels were associated with lower accuracy and concentration. Conclusions: This study suggests that adequate vitamin D levels may help preserve executive functions in people with schizophrenia and other organic mental disorders. Vitamin D supplementation is recommended in treatments to improve clinical outcomes and quality of life for these patients. Early detection and intervention are crucial to prevent further cognitive decline.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.